期刊文献+

促排汤对多囊卵巢综合征胰岛素抵抗影响的临床研究 被引量:8

下载PDF
导出
摘要 目的:观察促排汤治疗多囊卵巢综合征(PCOS)患者的疗效及其对胰岛素抵抗(IR)的影响。方法:将100例患者随机分为2组各50例,治疗组以促排汤治疗,对照组以二甲双胍治疗;均治疗6月,观察2组治疗前、后及停药4月后血清黄体生成素(LH)、卵泡刺激素(FSH)、睾酮(T)水平、胰岛素抵抗指数(IR)I等变化情况,并于停药4月后评价临床疗效。结果:治疗组临床疗效和血清激素水平的改善情况明显优于对照组(P<0.01);2组治疗后胰岛素抵抗均得到明显改善(P<0.01),但2组间比较差异不大(P>0.05)。结论:促排汤治疗PCOS可改善胰岛素抵抗,近期、远期疗效均良好。
作者 岑怡
出处 《新中医》 CAS 2013年第5期79-81,共3页 New Chinese Medicine
  • 相关文献

参考文献7

  • 1Franks S. Polycystic ovary syndrome in adolescents[J]. IntJ Obes(Lond), 2008, 32(7): 1035-1041.
  • 2Rautio K, Tapanainen JS, Ruokonen A, et al. Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study [J]. Human Reproduction, 2006, 21(6): 1400-1407.
  • 3Ovalle E, Azziz R. Insulin resistance, polycystic ovary syndrome and Type 2 diabetes mellitus[J]. Fertil Steril, 2002, 77(6): 1095-1105.
  • 4Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81 (1): 19-25.
  • 5李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:139
  • 6.中药新药临床研究指导原则:第1辑[S].[S].中华人民共和国卫生部,1993.215-218.
  • 7谈珍瑜,邹芝香,尤昭玲,付灵梅,冯光荣,熊利,唐媛.补肾活血方对PCO大鼠瘦素、胰岛素和睾酮影响的实验研究[J].新中医,2006,38(12):87-88. 被引量:15

二级参考文献23

  • 1黄健康,李启富.胰岛素抵抗与多囊卵巢综合征[J].医学综述,2005,11(5):389-391. 被引量:8
  • 2乐杰.妇产科学[M].北京:人民卫生出版社,2002.148-149.
  • 3Pantanetti P, Garrapa GG, Mantero F, et al. Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens,2004,26:387-398.
  • 4Diamanti-Kandarakis E, BergieleA. The influence of obesity on hyperandrogenism and infertility in the female. Obesity Reviews ,2001, 2:231-238.
  • 5Ciampelli M , Leoni F , Lattanzi F , et al. A pilot study of the long 2 term effects of acipimox in polycystic ovarian syndrome. Hum Reprod, 2002 ,17:647-653.
  • 6Marsden PJ , Murdoch AP , Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol , 2001 ,55:191-199.
  • 7Dunaif A. Insulin resistance and the polycystic ovary syndrome:mechanism and implications for pathogenesis. Endocr Rev, 1997,18 : 774 - 800.
  • 8Barzilai N, Wang J, Massilon D, et al. Leptin selesctively decreases visceral adiposity and enhances insulin action. J Clin Invest, 1997,100:3105-3110.
  • 9Farah L, Lazenby A J, Boots LR, et al. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists(Alabama Professional Electrology Association Study Group ). J Reprod Med, 1999,44:870-974.
  • 10Diamanti-Kandarakis E, Kouli CR, Bergiele AT ,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbost hormonal and metabolic profile. J Clin Endocrinol Metab, 1999, 84: 4006-4011.

共引文献284

同被引文献137

引证文献8

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部